Spin trapping of nitric oxide by aci anions of nitroalkanes.
Krzysztof J Reszka, Piotr Bilski, Colin F Chignell
Index: Nitric Oxide 10(2) , 53-9, (2004)
Full Text: HTML
Abstract
In alkaline solutions, nitroalkanes (RCH2NO2) undergo deprotonation and rearrange to an aci anion (RHC=NO2-), which may function as a spin trap. Using electron paramagnetic resonance (EPR) spectroscopy, we have investigated suitability of aci anions of a series of nitroalkanes (CH3NO2, CH3CH2NO2, CH3(CH2)2NO2, and CH3(CH2)3NO2) to spin trap nitric oxide (*NO). Based on the observed EPR spectra, the general structure of the adducts, formed by addition of *NO to RHC=NO2-, was identified as nitronitroso dianion radicals of general formula [RC(NO)NO2]*2- in strong base (0.5 M NaOH), and as a mono-anion radical [RCH(NO)NO2]*- in alkaline buffers, pH 10-13. The hyperfine splitting on 14N in the -NO2 moiety (11.2-12.48 G) is distinctly different from the splitting on 14N in the -NO moiety of the adducts (5.23-6.5 G). The structure of the adducts was verified using 15N-labeled *NO, which produced radicals, in which triplet due to splitting on 14N (I = 1) in 14NO/aci nitro adducts was replaced by a doublet due to 15N (I = 1/2) in 15NO/aci nitro adducts. EPR spectra of aci nitromethane/NO adduct recorded in NaOH and NaOD (0.5 M) showed that the hydrogen at alpha-carbon can be exchanged for deuterium, consistent with structures of the adducts being [CH(NO)NO2]*2- and [CD(NO)NO2]*2-, respectively. These results indicate that nitroalkanes could potentially be used as prototypes for development of *NO-specific spin traps suitable for EPR analysis.
Related Compounds
Related Articles:
2015-09-04
[J. Chromatogr. A. 1410 , 1-8, (2015)]
Performance of graphene sheets as stationary phase for capillary gas chromatographic separations.
2015-06-19
[J. Chromatogr. A. 1399 , 74-9, (2015)]
Disposition and metabolism of 1-nitropropane in rats and chimpanzees.
1989-09-01
[Biomed. Environ. Sci. 2(3) , 249-64, (1989)]
2000-03-01
[Se Pu 18(2) , 128-30, (2000)]
1994-10-13
[Eur. J. Pharmacol. 264(1) , 49-54, (1994)]